These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 1441294)

  • 1. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombolytic action of urokinase preparation covalently bound to modified thrombin].
    Maksimenko AV; Tishvhenko EG; Petrov AD; Orekhova NM; Ragimov SE
    Biull Eksp Biol Med; 1988 Sep; 106(9):322-4. PubMed ID: 3167185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
    Abe T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):122-36. PubMed ID: 2427393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of thymoptin on enzymatic fibrinolysis].
    Andreenko GV; Ashmarin IP; Zazhireĭ VD; Livshits VA; Serebriakova TN; Podorol'skaia LV
    Vopr Med Khim; 1989; 35(5):108-11. PubMed ID: 2617925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology of the thrombolytic enzyme preparation brinase.
    Frisch EP
    Semin Thromb Hemost; 1989 Jul; 15(3):341-6. PubMed ID: 2688105
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombolytic effect of urokinase upon various methods of administration into the body].
    Andreenko GV; Serebriakova TN; Podorol'skaia LV; Afanasenko GA; Liaginskiĭ AV; Raevskaia AK
    Vopr Med Khim; 1992; 38(1):44-6. PubMed ID: 1441294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.